BCL2 and neoplasm: The mice treated with Bcl-2 KD + PD-1 antibody or Bcl-2 OE + PD-1 antibody exhibited tumor growth comparable to that in mice treated with only the mouse anti-PD-1 antibody, suggesting that genetic manipulation of Bcl-2 had no effect on antitumor immunity (Fig. 1J).